Kimberly Chew will present, "MDMA: The Science Behind the FDA Approval Process," at The Emerald Conference presented by MJBizScience on Wednesday, April 3, 2024.
Join for an insightful exploration into the scientific underpinnings of the U.S. Food and Drug Administration’s approval process for MDMA, a groundbreaking compound showing promise in mental health treatments. This session aims to demystify the path from preclinical research to clinical trials, shedding light on the rigorous scientific evaluation that determines the safety and efficacy of MDMA for therapeutic use.
Whether you are a researcher, health care professional, policymaker or simply curious about the science behind regulatory decisions, this session offers a unique opportunity to engage with the intricacies of the FDA's approval process for MDMA and its potential impact on mental health care.
For more information, visit the event website.